Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
04/2010
04/15/2010US20100092555 Soft tablet containing high molecular weight cellulosics
04/15/2010US20100092554 Combination with an extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof
04/15/2010US20100092553 anti-misuse microparticulate oral pharmaceutical form
04/15/2010US20100092552 Low dose controlled release tablet
04/15/2010US20100092551 Solid preparation comprising alogliptin and pioglitazone
04/15/2010US20100092550 Alka-eeze
04/15/2010US20100092549 Dosage Form Containing Two or More Active Pharmaceutical Ingredients in Different Physical Forms
04/15/2010US20100092548 Chewable softgel capsules
04/15/2010US20100092547 Compositions and methods for preventing and treating mucositis and weight loss
04/15/2010US20100092546 Topical and Transdermal Delivery of HIF-1 Modulators to Prevent and Treat Chronic Wounds
04/15/2010US20100092545 Polyethylene-oxide based films and drug delivery systems made therefrom
04/15/2010US20100092544 Adhesive composition for patch and use thereof
04/15/2010US20100092542 Compositions and methods for treatment of eye disorders
04/15/2010US20100092541 Compositions and methods for treatment of eye disorders
04/15/2010US20100092540 Drug delivery compositions and medical devices containing block copolymer
04/15/2010US20100092538 Nucleic Acids Encoding Spider Glue Proteins and Methods of Use Thereof
04/15/2010US20100092536 Implantable sensors and implantable pumps and anti-scarring agents
04/15/2010US20100092535 Nanoporous Drug Delivery System
04/15/2010US20100092533 Bioabsorbable Surgical Composition
04/15/2010US20100092532 Materials and Methods for Treating and Managing Angiogenesis-Mediated Diseases
04/15/2010US20100092529 Method for Acaricidal and Microbicidal Treatment of Textile Materials
04/15/2010US20100092528 Fructan-based epilatory compositions
04/15/2010US20100092526 Nanoemulsion therapeutic compositions and methods of using the same
04/15/2010US20100092525 Medical device
04/15/2010US20100092449 Treatment of Pompe's Disease
04/15/2010US20100092448 Local control of inflammation
04/15/2010US20100092406 Systems, Methods, and Compositions for Treatment and Use of a Palatal Patch
04/15/2010US20100092403 aerosol sprays; fast onset of effect
04/15/2010US20100092402 Treatment of respiratory disease
04/15/2010US20100092401 Immune response modifier formulations
04/15/2010US20100092400 Salicylic Acid Composition
04/15/2010US20100092399 Methods of treating or preventing inflammation and hypersensitivity with oxidative reductive potential water solution
04/15/2010US20100092398 Antimicrobial compositions and applications therefore
04/15/2010US20100092397 Method For Treatment of COPD and Other Pulmonary Diseases
04/15/2010US20100092393 Tunable hydrogel microparticles
04/15/2010US20100092388 Anthracycline Derivatives
04/15/2010DE4315525B4 Pharmazeutische Zusammensetzung Pharmaceutical composition
04/15/2010DE102008049522A1 Granulat, insbesondere als pharmazeutisches Vehikel für lipophile Arzneistoffe Granules, especially as a pharmaceutical vehicle for lipophilic drugs
04/15/2010CA2755968A1 Substituted 3-arylsulfonyl-pyrazolo[1,5-a]pyrimidines, serotonin 5-ht6 receptor antagonists and methods for the production and use thereof
04/15/2010CA2752429A1 Chewable gelled emulsions
04/15/2010CA2742966A1 Chewable gelled emulsions
04/15/2010CA2740125A1 Multifunctional self-assembling polymeric nanosystems
04/15/2010CA2740000A1 Improved amino lipids and methods for the delivery of nucleic acids
04/15/2010CA2739897A1 Aerosol fluoroquinolone formulations for improved pharmacokinetics
04/15/2010CA2739822A1 Liposomal systems comprising sphingomyelin
04/15/2010CA2739710A1 Pharmaceutical composition
04/15/2010CA2739380A1 Amorphous rotigotine transdermal system
04/15/2010CA2739361A1 Ready-to-use, stable emulsion
04/15/2010CA2739353A1 Corticosteroid compositions and methods of treatments thereof
04/15/2010CA2739246A1 Sustained release drug delivery system
04/15/2010CA2738831A1 Tacrolimus preparation for external applications
04/15/2010CA2738630A1 Methods for treating or preventing pain using spicamycin derivatives
04/15/2010CA2737764A1 Biocompatible polymers for medical devices
04/15/2010CA2737763A1 Phase-separated biocompatible polymer compositions for medical uses
04/15/2010CA2737401A1 Iron source product in the form of capsules and process for their preparation
04/15/2010CA2737400A1 Pharmaceutical formulation 514
04/15/2010CA2737391A1 Liquid pharmaceutical formulation containing paracetamol
04/15/2010CA2737255A1 Modified release emulsions for application to skin or vaginal mucosa
04/15/2010CA2737102A1 Benzimidazole anthelmintic compositions
04/15/2010CA2735962A1 Crosslinked polymers
04/14/2010EP2174657A1 Iron source product in the form of capsules and process for their prepartion
04/14/2010EP2174656A1 Microparticles of alginate modified with rgd as a release system for medicines
04/14/2010EP2174655A1 Spherical microcapsules comprising GLP-1 peptides, their production and use
04/14/2010EP2174654A1 Micronized composition of a 2, 4- disubstituted phenol derivative
04/14/2010EP2174653A1 Dry powder inhaler formulations comprising surface-modified particles with anti-adherent additives
04/14/2010EP2174652A2 Oral pharmaceutical desmopressin composition
04/14/2010EP2174651A1 A polymer-free hydrogel
04/14/2010EP2174650A1 Modified release emulsions for application to skin or vaginal mucosa
04/14/2010EP2174647A1 Gel-like composition for external application comprising adenine compound
04/14/2010EP2174646A1 Inverted vesicle
04/14/2010EP2173859A2 Soft gel systems in modulating stem cell development
04/14/2010EP2173775A1 Hyaluronic acid derivatives containing groups able to release no
04/14/2010EP2173555A2 Use of a material based on a thermoplastic polymer having a high content of antioxidants for packaging dianhydrohexitols
04/14/2010EP2173391A2 Improvements relating to skin dressings
04/14/2010EP2173390A2 Improvements relating to skin dressings
04/14/2010EP2173357A2 Metal complexes incorporated within biodegradable nanoparticles and their use
04/14/2010EP2173344A1 Treatment or prophylaxis or neurological or neuropsychiatric disorders via ocular administration
04/14/2010EP2173330A1 Reservoir system comprising a closed membrane
04/14/2010EP2173329A1 Tolterodine bead
04/14/2010EP2173328A1 Solid valsartan composition
04/14/2010EP2173327A2 Technology for the preparation of microparticles
04/14/2010EP2173326A2 Dermatological composition containing calcitriol lipidic vesicles, method for preparing same and use thereof
04/14/2010EP2173325A1 Peptide slow-release formulations
04/14/2010EP2173323A2 Stimulating gel
04/14/2010EP2173322A2 A pharmaceutical composition comprising polyaphron dispersion
04/14/2010EP2173321A2 Tablettable formulations of lipophilic health ingredients
04/14/2010EP2173320A1 Metronidazole containing extended release floating pharmaceutical composition
04/14/2010EP2173189A2 Method for producing stable powder compositions
04/14/2010EP2173184A1 Omega-3 fatty acid fortified composition
04/14/2010EP2173172A1 Orally disintegrating tablet compositions of lamotrigine
04/14/2010EP1663229B1 Pharmaceutical combinations of hydrocodone and naltrexone
04/14/2010EP1586315B1 Skin lightening composition
04/14/2010EP0935616B2 Process for the manufacture of adhesives with low level of residual monomers
04/14/2010CN1994277B Solid preparation of salvianolic acid A of red sage root and preparation process thereof
04/14/2010CN1973897B Quality control method for puerperal blood clot dispersing tablet
04/14/2010CN1968694B An analgesic pharmaceutical composition
04/14/2010CN1965802B Injectable hydrogel preparation of pegylated medicament and preparing method thereof
04/14/2010CN1951434B Soft capsule having fatigue-resisting radiation-resisting function and preparation method thereof
04/14/2010CN1943560B Sandwich structure magnetic composite micro ball with functional shell layer and its preparing method
04/14/2010CN1935230B Chinese medicine injection preparation and its preparing method